Erratum to "Glucose tolerance normalization following transplantation of pig pancreatic primordia into non-immunosuppressed diabetic ZDF rats" [Transplant Immunology 16 (2006) 176-184] (DOI:10.1016/j.trim.2006.08.007);Glucose tolerance normalization following transplantation of pig pancreatic primordia into non-immunosuppressed diabetic ZDF rats

Transplant Immunology

Volumn 16, Issue 3-4, 2006, Pages 176-184

  Rogers, Sharon A ^a   Chen, Feng ^a   Talcott, Mike ^a   Liapis, Helen ^a   Hammerman, Marc R ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Beta cell; Organogenesis; Type 2 diabetes; Xenotransplantation

Indexed keywords

GLUCOSE; HUMAN INSULIN; ISOPHANE INSULIN; PIG INSULIN; STREPTOZOCIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EMBRYO; EMBRYO DEVELOPMENT; FEMALE; GLUCOSE TOLERANCE; IMMUNOSUPPRESSIVE TREATMENT; IN VITRO STUDY; INSULIN RELEASE; INSULIN SENSITIVITY; LIVER; MALE; MESENTERY LYMPH NODE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NUCLEOTIDE SEQUENCE; ORAL GLUCOSE TOLERANCE TEST; PANCREAS; PANCREAS ISLET BETA CELL; PANCREAS TRANSPLANTATION; PRIORITY JOURNAL; RAT; RAT STRAIN; STREPTOZOCIN DIABETES; SWINE;

EID: 33751318505     PISSN: 09663274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trim.2007.01.008     Document Type: Erratum

References (32)

1. Phillips M.S., Hammond H.A., Dugan V., Hey P.J., Caskey C.J., and Hess J.F. Leptin receptor missense mutation in the fatty Zucker rat. Nat Genet 13 1 (1996) 18-19
2. Peterson R.G., Shaw W.N., Neel M.A., Little L.A., and Eichberg L. Zucker diabetic fatty rat as a model for non-insulin-dependent diabetes. ILAR News 32 3 (1990) 16-19
3. Clark J.B., Palmer C.J., and Shaw W.N. The diabetic Zucker fatty rat. Proc Soc Exp Biol Med 173 1 (1983) 68-75
4. Rogers S.A., Chen F., Talcott M., and Hammerman M.R. Islet cell engraftment and control of diabetes in rats following transplantation of pig pancreatic anlagen. Am J Physiol 286 4 (2004) E502-E509
5. Rogers S.A., Liapis H., and Hammerman M.R. Normalization of glucose post-transplantation of pig pancreatic anlagen into non-immunosuppressed diabetic rats depends on obtaining anlagen prior to embryonic day 35. Transpl Immunol 14 1 (2005) 67-75
6. Chang A.Y., and Dinai A.R. Chemically and hormonally induced diabetes mellitus. In: Volk B.W., and Arquilla E.R. (Eds). The diabetic pancreas (1985), Plenum, New York 415-438
7. Rogers S.A., Liapis H., and Hammerman M.R. Intraperitoneal transplantation of pancreatic anlagen. ASAIO J 49 5 (2003) 527-532
8. Alumets L., Hakanson R., and Sundler F. Ontogeny of endocrine cells in porcine gut and pancreas. Gastroenterology 85 6 (1983) 1359-1372
9. Curry D.L., Bennett L.L., and Grodsky G.M. Dynamics of insulin secretion by the perfused rat pancreas. Endocrinology 83 3 (1968) 572-584
10. Bottino R., and Trucco M. Multifaceted therapeutic approaches for a multigenic disease. Diabetes 54 Supplement 2 (2005) S79-S86
11. Friedman A.L., and Friedman E.A. Pancreas transplantation for type 2 diabetes at US transplant centers. Diabetes Care 25 10 (2002) 1896
12. Danovitch G.M., Cohen D.J., Weir M.R., Stock R.G., Bennett W.M., Christiansen L.L., et al. Current status of kidney and pancreas transplantation in the United States 1994-2003. Am J Transplant 5 Part 2 (2005) 904-915
13. Sachs D.H. The pig as a potential xenograft donor. Vet Immunol Immunopathol 43 1-3 (1994) 185-191
14. Hering B., Wijkstrom M., Graham M., Hardstedt M., Aasheim T.C., Jie T., et al. Prolonged diabetes reversal after intraportal xenotransplantation of wild-type porcine islets in immunosuppressed nonhuman primates. Nat Med 12 3 (2006) 301-303
15. Cardona K., Korbutt G.S., Milas Z., Lyon J., Cano J., Jiang W., et al. Long-term survival of neonatal porcine islets in non-human primates by targeting costimulation pathways. Nat Med 12 3 (2006) 204-306
16. Hegre O.D., Leonard R.L., Erlandsen S.L., McEvoy J.A., Elde R.P., and Lazarow A. Transplantation of islet tissue in the rat. Acta Endocrinol 205 Supp 1976 (1976) 257-278
17. Brown J., Clark W.R., Molnar I.G., and Mullen Y.S. Fetal pancreas transplantation for reversal of streptozotocin-induced diabetes in rats. Diabetes 25 1 (1976) 56-64
18. Brown J., Heininger D., Kuret J., and Mullen Y. Islet cells grow after transplantation of fetal pancreas and control of diabetes. Diabetes 30 1 (1981) 9-13
19. Brown J., Mullen Y., Clark W., Molnar G., and Heininger D. Importance of hepatic portal circulation for insulin action in streptozotocin-diabetic rats transplanted with fetal pancreases. J Clin Invest 64 6 (1979) 1688-1694
20. Hammerman M.R. Windows of opportunity for organogenesis. Transpl Immunol 15 1 (2005) 1-8
21. Eventov-Friedman S., Katchman H., Shezen E., Arnovich A., Tchorsh D., Dekel B., et al. Embryonic pig liver, pancreas, and lung as a source for transplantation: optimal organogenesis without teratoma depends on distinct time windows. Proc Natl Acad Sci U S A 102 8 (2005) 2928-2933
22. Eventov-Friedman S., Tchorsh D., Katchman H., Shezan E., Arnovich A., Hecht G., et al. Embryonic pig pancreatic tissue transplantation for the treatment of diabetes. PLoS Med 3 7 (2006) 1165-1177
23. Butcher G.W., and Howard J.C. The MHC of the laboratory rat Rattus norvegicus. In: Weir D.M. (Ed). Genetics and molecular immunology (1986), Oxford Blackwell 101.2
24. Tirabassi R.S., Flanagan J.F., Wu T., Kislauskis E.H., Birckbichler P.J., and Guberski D.L. The BBZR/Wor rat model for investigating the complications of type 2 diabetes mellitus. ILAR J. 45 3 (2004) 292-302
25. Blackard W.G., and Nelson N.C. Portal and peripheral vein immunoreactive insulin concentrations before and after glucose infusions. Diabetes 19 5 (1970) 302-306
26. Ryan E.A., Laken J.R.T., Rajotte R.V., Korbutt G.S., Kin T., Imes S., et al. Clinical outcomes and insulin secretion after islet transplantation with the Edmonton protocol. Diabetes 50 4 (2001) 710-719
27. Adler S.H., Bensinger S.J., and Turka L.A. Stemming the tide of rejection. Nat Med 8 2 (2002) 107-108
28. Drukker M., Katchman H., Katz G., Even-Tov Friedman S., Shezen E., Hornstein E., et al. Human embryonic stem cells and their differentiated derivatives are less susceptible to immune rejection that adult cells. Stem Cells 24 2 (2006) 221-229
29. Fandrich F., Lin X., Chai G.X., Schulze M., Ganten D., Bader M., et al. Preimplantation-stage stem cells induce long-term allogeneic graft acceptance without supplementary host conditioning. Nat Med 8 2 (2002) 171-178
30. Liechty K.W., MacKenzie T.C., Shaaban A.E., Radu A., Moseley A.B., Deans R., et al. Human mesenchymal stem cells engraft and demonstrate site-specific differentiation after in utero transplantation in sheep. Nat Med 6 11 (2000) 1282-1286
31. Yokoo T., Fukui A., Ohashi T., Miyazaki Y., Utsonomiya Y., Kawamura T., et al. Xenobiotic kidney organogenesis from human mesenchymal stem cells using a growing rodent embryo. J Am Soc Nephrol 17 4 (2006) 1026-1034
32. Eloy R., Haffen K., Kedinger M., and Grenier J.F. Chick embryo pancreatic transplants reverse experimental diabetes of rats. J Clin Invest 64 2 (1979) 361-373